Lykos Therapeutics’ Post

View organization page for Lykos Therapeutics

22,369 followers

Today, we announce changes to the executive team. Amy Emerson will step down as CEO; Lykos COO, Michael Mullette, will serve as the interim CEO and Dr. David Hough will assume the role of CMO. We thank Amy for her leadership over the past decade and look forward to the future of working with the FDA to bring this potential new option to people living with PTSD. https://lnkd.in/eBYSZt2z

  • No alternative text description for this image

Amy Emerson thank you for the decade + of support, leadership and dedication to MDMA assisted therapy research and training, Zendo harm reduction services and so much more. Your major, foundational role in spearheading the entire psychedelic medicine industry is undeniable.

Jess M. Jones

Bilingual LCSW. Psychedelic-assisted psychotherapist working in clinical research.

7mo

Thank you for your leadership, Amy! It’s inspirational and has changed lives.

Edmund Greenidge JD, LLM, CCEP

Senior Director, Compliance at Summit Therapeutics

7mo

Congratulations Dave Hough!

Like
Reply
Emily Kulpa, PharmD

✨Exploring the Intersection of Psychedelics, Human Potential & Innovation 💊➡️🍄🟫 Psilocybin Facilitator | Reimagining Systems for a Thriving Future✨

7mo

Amy Emerson Thank you for all you’ve done to push this therapy forward. I hope Lykos Therapeutics continues to put females in leadership, board, and c-suite positions.

Allison Rosenthal

Chief Commercial Officer, Lykos Therapeutics

7mo

Thank you for your leadership Amy Emerson and best of continued success to you Michael Mullette!

Angela Terhune Hargrove

President Angela Hargrove Consulting - Senior Clinical Research Consultant | 35+ yrs Experience | Phase I–IV | All Therapeutic Areas | Psychedelics | CNS | Business Development | Site Network Builder

7mo

Amy Emerson, it's been a privilege to watch you navigate the waters in this emerging sector. Thank you for all your hard work. My husband is alive today because of a chance meeting with Rick many years ago. Hence, my passion for working in psychedelic research. Wishing you much success in your future endeavors, and I hope to collaborate in the near future. Thank you, Amy!

Cole Butler, LPCC, ADDC, MACP

Mental Health Therapist | Writer | Community Builder

7mo

She did a great job! Michael sounds like a great choice to continue to lead the charge

Like
Reply
Brad Burge

Psychedelic PR, Communications, and Marketing

7mo

Amy Emerson, words cannot convey the impact of what you have accomplished during your time at MAPS, MAPS PBC, and Lykos. You've transformed the field of mental health, and with it countless lives. It's an honor to have worked alongside you for a decade, and I'm so excited for what's next for you. Thank you.

Michele Weitz, MA, RQAP-GCP

Principal @ GCP Vision Consulting | Trusted Quality Culture Champion and Advisor | Purpose-Fit GxP Compliant Procedures and Best Practices | Proactive Inspection Readiness

6mo

It’s been a privilege to be a part of your journey over many years, Amy Emerson. Few leaders in this industry have the courage to openly demonstrate the dedication, compassion, and personal regard for employees that have marked your career with MAPS, MAPS PBC, and Lykos. You have worked tirelessly to give rise to the destigmatization of Psychedelic Medicine, and you have changed lives. Can’t wait to see what you do next!

Johnnie Bone

Capture Manager at Northrop Grumman

7mo

Congratulations Dave! 👏

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics